From 17 to 23 December 2025, under the framework of the China–Solomon Islands Minimally Invasive Urology Surgery Center ...
Botensilimab (Fc-enhanced anti–cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti–PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas ASCO Guidelines ...
Urinary incontinence (UI) after radical prostatectomy is a common and distressing complication for men with prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback